Summary
Effective clearance of apoptotic cells by macrophages is essential for immune homeostasis. The transcriptional pathways that allow macrophages to sense and respond to apoptotic cells are poorly defined. We demonstrate here that LXR signaling is important for both apoptotic cell clearance and the maintenance of immune tolerance. Apoptotic cell engulfment activates LXR and thereby induces the expression of Mer, a receptor tyrosine kinase critical for phagocytosis. LXR null macrophages exhibit a selective defect in phagocytosis of apoptotic cells and an aberrant pro-inflammatory response to them. As a consequence of these defects, mice lacking LXRs manifest a breakdown in self-tolerance and develop autoantibodies and autoimmune glomerulonephritis. Treatment with an LXR agonist ameliorates disease progression in mouse models of Lupus-like autoimmunity. Thus, activation of LXR by apoptotic cells engages a virtuous cycle that promotes their own clearance and couples engulfment to the suppression of inflammatory pathways.
Macrophages are professional phagocytic cells that orchestrate innate immune responses and display remarkable phenotypic diversity at different anatomical locations. However, the mechanisms that control the heterogeneity of tissue macrophages are not well characterized. Here, we report that the nuclear receptor LXRα is essential for the differentiation of macrophages in the marginal zone (MZ) of the spleen. LXR deficient mice are defective in the generation of MZ and metallophilic macrophages, resulting in abnormal responses to blood-borne antigens. Myeloid specific expression of LXRα or adoptive transfer of wild-type monocytes rescues the MZ microenvironment in LXRα deficient mice. These results demonstrate that LXRα signaling in myeloid cells is crucial for the generation of splenic MZ macrophages and reveal an unprecedented role for a nuclear receptor in the generation of specialized macrophage subsets.
MMMT are the most aggressive tumors and their behavior strongly resembles that of high-grade endometrial adenocarcinoma. Prognostic factors affecting survival were stage, histology, tumor size, and parity.
Artículo de publicación ISIContribution over time of human papillomavirus (HPV) types in human cancers has been poorly documented. Such data is fundamental
to measure current HPV vaccines impact in the years to come. We estimated the HPV type-specific distribution in a
large international series of invasive cervical cancer (ICC) over 70 years prior to vaccination. Paraffin embedded ICC cases
diagnosed between 1940 and 2007 were retrieved from eleven countries in Central-South America, Asia and Europe. Included
countries reported to have low-medium cervical cancer screening uptake. Information on age at and year of diagnosis was collected
from medical records. After histological confirmation, HPV DNA detection was performed by SPF-10/DEIA/LiPA25 (version1).
Logistic regression models were used for estimating the adjusted relative contributions (RC) of HPV16 and of HPV18
over time. Among 4,771 HPV DNA positive ICC cases, HPV16 and HPV18 were the two most common HPVs in all the decades
with no statistically significant variations of their adjusted-RC from 1940–59 to 2000–07 (HPV16—from 61.5 to 62.1%, and
HPV18—from 6.9 to 7.2%). As well, the RC of other HPV types did not varied over time. In the stratified analysis by histology,
HPV16 adjusted-RC significantly increased across decades in adenocarcinomas. Regarding age, cases associated to either
HPV16, 18 or 45 were younger than those with other HPV types in all the evaluated decades. The observed stability on the
HPV type distribution predicts a high and stable impact of HPV vaccination in reducing the cervical cancer burden in future
vaccinated generations.
What’s new?
Evaluation of the success or failure of human papillomavirus (HPV) vaccination programs depends in part on knowledge of the
historical contribution of the different HPV types to human cancer. The present study analyzed HPV type-specific relative contributions
to invasive cervical cancer (ICC) over a 70-year period prior to the implementation of HPV vaccination. The relative
contributions of different HPV types, including those for which a vaccine is now available, were found to be constant across
decades. The findings indicate that HPV vaccination will have a high, stable impact on cervical cancer reduction.Instituto de Salud Carlos III (Spanish Government); Grant numbers: FIS PI030240, FIS PI061246, RCESP C03/09, RTICESP
C03/10, RTIC RD06/0020/0095, CIBERESP; Grant sponsor: Age`ncia de Gesti o d’Ajuts Universitaris i de Recerca; Grant numbers: AGAUR
2005SGR 00695, 2009SGR126; Grant sponsor: Marat o de TV3 Foundation; Grant number: 051530; Grant sponsor: GlaxoSmithKline
Biologicals, Sanofi Pasteur MSD & Merck & Co, Inc who had no role in the data collection, analysis, or interpretation of the results
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.